Daiwa Securities Group
TEVA icon

Daiwa Securities Group’s Teva Pharmaceuticals TEVA Stock Holding History

Daiwa Securities Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.97M Buy
117,065
+11,100
+10% +$370K 0.01% 564
2026
Q1 		$3.19M Buy
105,965
+5,100
+5% +$164K 0.01% 571
2025
Q4 		$3.15M Buy
100,865
+1,300
+1% +$32K 0.01% 557
2025
Q3 		$2.01M Buy
99,565
+3,500
+4% +$61.5K 0.01% 633
2025
Q2 		$1.61M Buy
96,065
+2,500
+3% +$40.3K 0.01% 660
2025
Q1 		$1.44M Buy
93,565
+600
+0.6% +$10.7K 0.01% 668
2024
Q4 		$2.05M Buy
92,965
+3,500
+4% +$63.7K 0.01% 593
2024
Q3 		$1.61M Buy
89,465
+8,100
+10% +$142K 0.01% 624
2024
Q2 		$1.32M Sell
81,365
-34,328
-30% -$529K 0.01% 650
2024
Q1 		$1.63M Buy
115,693
+4,170
+4% +$52.6K 0.01% 606
2023
Q4 		$1.17M Sell
111,523
-13,921
-11% -$130K 0.01% 657
2023
Q3 		$1.28M Sell
125,444
-758
-0.6% -$7.06K 0.01% 608
2023
Q2 		$951K Sell
126,202
-3,645
-3% -$29.6K 0.01% 680
2023
Q1 		$1.15M Buy
129,847
+12,033
+10% +$119K 0.01% 627
2022
Q4 		$1.07M Sell
117,814
-2,411
-2% -$21K 0.01% 633
2022
Q3 		$971K Sell
120,225
-17,624
-13% -$156K 0.01% 652
2022
Q2 		$1.04M Sell
137,849
-17,446
-11% -$152K 0.01% 649
2022
Q1 		$1.46M Buy
155,295
+18,693
+14% +$156K 0.01% 592
2021
Q4 		$1.09M Sell
136,602
-11,053
-7% -$99.8K 0.01% 684
2021
Q3 		$1.44M Buy
147,655
+11,753
+9% +$110K 0.01% 586
2021
Q2 		$1.34M Buy
135,902
+9,330
+7% +$98.8K 0.01% 563
2021
Q1 		$1.46M Sell
126,572
-9,233
-7% -$106K 0.01% 514
2020
Q4 		$1.31M Sell
135,805
-35,763
-21% -$343K 0.01% 507
2020
Q3 		$1.55M Sell
171,568
-27,472
-14% -$291K 0.01% 397
2020
Q2 		$506K Hold
199,040
– – 0.01% 534
2020
Q1 		$1.79M Sell
199,040
-24,400
-11% -$250K 0.02% 345
2019
Q4 		$2.19M Buy
223,440
+11,853
+6% +$106K 0.02% 336
2019
Q3 		$1.46M Buy
211,587
+171,004
+421% +$1.31M 0.01% 411
2019
Q2 		$375K Buy
40,583
+5,200
+15% +$62.7K ﹤0.01% 751
2019
Q1 		$555K Sell
35,383
-41,410
-54% -$730K ﹤0.01% 613
2018
Q4 		$1.19M Buy
76,793
+42,610
+125% +$874K 0.01% 412
2018
Q3 		$736K Buy
34,183
+2,329
+7% +$54.1K 0.01% 555
2018
Q2 		$775K Buy
31,854
+2,000
+7% +$40.8K 0.01% 540
2018
Q1 		$3.07M Buy
29,854
+3,354
+13% +$65.5K 0.02% 303
2017
Q4 		$502K Hold
26,500
– – ﹤0.01% 614
2017
Q3 		$466K Sell
26,500
-65,200
-71% -$1.47M ﹤0.01% 601
2017
Q2 		$3.04M Buy
91,700
+13,600
+17% +$421K 0.02% 262
2017
Q1 		$2.51M Sell
78,100
-11,200
-13% -$382K 0.02% 307
2016
Q4 		$3.24M Buy
89,300
+34,300
+62% +$1.37M 0.02% 218
2016
Q3 		$2.53M Buy
55,000
+51,848
+1,645% +$2.71M 0.02% 266
2016
Q2 		$1.19M Buy
+3,152
New +$168K 0.01% 368

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Daiwa Securities Group's TEVA Position: Q2 2026 in Review

Daiwa Securities Group increased its Teva Pharmaceuticals (TEVA) stake by 10% in Q2 2026, buying an estimated $370K and bringing the position to 117,065 shares worth $3.97M. The position accounts for 0.01% of the portfolio, ranked #564.

Daiwa Securities Group first reported a position in TEVA in Q2 2016 and has held it in 41 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Daiwa Securities Group held 117,065 shares of Teva Pharmaceuticals worth $3.97M as of Q2 2026.
  • Daiwa Securities Group bought 11,100 Teva Pharmaceuticals shares in Q2 2026, an estimated $370K.
  • Teva Pharmaceuticals made up 0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #564 holding.
  • Daiwa Securities Group first reported a position in Teva Pharmaceuticals in Q2 2016 and has held it in 41 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.